Novartis Ag (NVS) Return on Assets [ROA] (2009 - 2026)
Novartis Ag (NVS) reported Return on Assets [ROA] of 10.60% for Q2 2026, down 2.75 percentage points from 13.35% a year earlier and down 1.18 percentage points from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Novartis Ag posted Return on Assets [ROA] of 13.10%, up 1.29 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of +6.54 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at 11.81% in FY2024 (-1.86 pp), 13.67% in FY2023 (+8.08 pp), 5.58% in FY2022 (-12.92 pp) and 18.51% in FY2021 (+11.95 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2023.
- Year over year, Return on Assets [ROA] gained in two of the last eight quarters, with an average year-over-year change of -0.60 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q4 2021 (a gain of 12.72 percentage points); the low point was Q4 2022 (a drop of 13.09 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 11.78% (Q1 2026), 12.80% (Q4 2025) and 13.59% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 13.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.60% |
| Mar 31, 2026 | 11.78% |
| Dec 31, 2025 | 12.80% |
| Sep 30, 2025 | 13.59% |
| Jun 30, 2025 | 13.35% |
| Mar 31, 2025 | 12.72% |
| Dec 31, 2024 | 11.60% |
| Sep 30, 2024 | 17.51% |
| Jun 30, 2024 | 16.87% |
| Mar 31, 2024 | 15.70% |
| Dec 31, 2023 | 13.97% |
| Sep 30, 2023 | 7.01% |
| Jun 30, 2023 | 6.86% |
| Mar 31, 2023 | 6.12% |
| Dec 31, 2022 | 5.90% |
| Sep 30, 2022 | 18.06% |
| Jun 30, 2022 | 18.52% |
| Mar 31, 2022 | 18.81% |
| Dec 31, 2021 | 18.99% |
| Sep 30, 2021 | 8.00% |
API Access
Novartis Ag Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();